Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/27/15 → 01/25/22 |
Funding
- ICON Clinical Research: $176,562.50
Pfizer: An Open-Label Phase 1B Study of PF-04449913 (GLASDEGIB) in Combination with Azacitidine in Patients with Previously Untreated High-Risk Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia
- Schuster, Michael (PI)
- Gabig, Theodore (CoPI)
- Lan, Fengshuo (CoPI)
- Kiner-Strachan, Bonnie (CoPI)
Project: Research